Breaking Resistance: Successful Treatment of Refractory Nephrotic Syndrome with a Nonstandard Treatment (Upadacitinib) (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO0514; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Mycophenolic acid, prednisone, and other treatments, including Rituximab and tacrolimus, were ineffective or not tolerated. Its oral administration and tolerability make it a promising alternative. Further studies are needed to confirm safety and long-term outcomes."
Acute Kidney Injury • Glomerulonephritis • Immunology • Inflammation • Inflammatory Arthritis • Lupus Nephritis • Nephrology • Psoriatic Arthritis • Renal Disease • Seronegative Spondyloarthropathies
|